(Q37962479)

26 August 2017

title

Genetic epidemiology with a capital E, ten years after (English)

1 reference

26 August 2017

1 reference

2

Marta Gwinn

1 reference

26 August 2017

1

Muin J Khoury

1 reference

26 August 2017

3

Mindy Clyne

1 reference

26 August 2017

Wei Yu

4

1 reference

26 August 2017

language of work or name

1 reference

1 December 2011

1 reference

26 August 2017

1 reference

26 August 2017

volume

35

1 reference

26 August 2017

issue

8

1 reference

26 August 2017

page(s)

845-852

1 reference

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Outcomes of interest in evidence-based evaluations of genetic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Gene-environment interplay in common complex diseases: forging an integrative model—recommendations from an NIH workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

The significance of the complement system for the pathogenesis of age-related macular degeneration - current evidence and translation into clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

A vision for the future of genomics research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Causes and prevalence of visual impairment among adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Synopsis of preterm birth genetic association studies: the preterm birth genetics knowledge base (PTBGene).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Charting a course for genomic medicine from base pairs to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

What is the clinical utility of genetic testing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Genome-wide association studies in pharmacogenomics: untapped potential for translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

A haplotype map of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

A second generation human haplotype map of over 3.1 million SNPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

A network of investigator networks in human genome epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

A road map for efficient and reliable human genome epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Assessment of cumulative evidence on genetic associations: interim guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

The false-positive to false-negative ratio in epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Measuring the performance of markers for guiding treatment decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Strengthening the reporting of genetic risk prediction studies: The GRIPS Statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Comparative effectiveness research and genomic medicine: an evolving partnership for 21st century medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

The Emergence of Translational Epidemiology: From Scientific Discovery to Population Health Impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Complement factor H polymorphism in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Integrating epidemiology and genetic association: the challenge of gene-environment interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Genomewide association studies and assessment of the risk of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Genome-wide association studies for complex traits: consensus, uncertainty and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Case-control studies of gene-environment interaction: Bayesian design and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Use of genomic profiling to assess risk for cardiovascular disease and identify individualized prevention strategies--a targeted evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Commentary: Reporting standards are needed for evaluations of risk reclassification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Risk factors for age-related macular degeneration: Pooled findings from three continents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Using genetic variation and environmental risk factor data to identify individuals at high risk for age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Association between apolipoprotein E polymorphisms and age-related macular degeneration: A HuGE review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Genetic epidemiology with a capital "E".

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Gene--environment-wide association studies: emerging approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Methods for investigating gene-environment interactions in candidate pathway and genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

The meaning of translational research and why it matters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

A navigator for human genome epidemiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

GAPscreener: an automatic tool for screening human genetic association literature in PubMed using the support vector machine technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Phenopedia and Genopedia: disease-centered and gene-centered views of the evolving knowledge of human genetic associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

The impact of next-generation sequencing on genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

STrengthening the REporting of Genetic Association Studies (STREGA)-an extension of the STROBE statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

The Emergence of Networks in Human Genome Epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

An Introduction to Epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

Beyond odds ratios — communicating disease risk based on genetic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

21 January 2018

Handbook of Epidemiology

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

7 January 2021

Invited commentary: genes, environment, and hybrid vigor

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

7 January 2021

Reducing the Genetic Risk of Age-Related Macular Degeneration With Dietary Antioxidants, Zinc, and ω-3 Fatty Acids

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

7 January 2021

Assessment of Improved Prediction Beyond Traditional Risk Factors

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

7 January 2021

The Human Genome Epidemiology Network

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

7 January 2021

CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

7 January 2021

Prevalence of age-related maculopathy. The Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

7 January 2021

A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

7 January 2021

Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.20634

7 January 2021

Identifiers

DOI

10.1002/GEPI.20634

1 reference

26 August 2017

1 reference